Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities
Andria Stylianou, Christoforos Hadjichrysanthou, James E. Truscott, et al.
Parasites & Vectors (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?
Jaspreet Toor, Ramzi Alsallaq, James E. Truscott, et al.
Clinical Infectious Diseases (2018) Vol. 66, Iss. suppl_4, pp. S245-S252
Open Access | Times Cited: 100
Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium
Matthew R. Behrend, María‐Gloria Basáñez, Jonathan I. D. Hamley, et al.
PLoS neglected tropical diseases (2020) Vol. 14, Iss. 4, pp. e0008033-e0008033
Open Access | Times Cited: 87
Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections
Leroy Versteeg, Mashal M. Almutairi, Peter J. Hotez, et al.
Vaccines (2019) Vol. 7, Iss. 4, pp. 122-122
Open Access | Times Cited: 83
Vaccines for Human Schistosomiasis: Recent Progress, New Developments and Future Prospects
Adebayo J. Molehin, Donald P. McManus, Hong You
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2255-2255
Open Access | Times Cited: 53
A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments
Arif Jamal Siddiqui, Jyoti Bhardwaj, Juhi Saxena, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 792-792
Open Access | Times Cited: 18
A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area
W Keitel, Gail E. Potter, David Diemert, et al.
Vaccine (2019) Vol. 37, Iss. 43, pp. 6500-6509
Open Access | Times Cited: 53
Sm‐p80‐based schistosomiasis vaccine: double‐blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission‐blocking efficacy
Weidong Zhang, Adebayo J. Molehin, Juan U. Rojo, et al.
Annals of the New York Academy of Sciences (2018) Vol. 1425, Iss. 1, pp. 38-51
Open Access | Times Cited: 52
Advancing the Development of a Human Schistosomiasis Vaccine
Peter J. Hotez, María Elena Bottazzi, Jeffrey M. Bethony, et al.
Trends in Parasitology (2018) Vol. 35, Iss. 2, pp. 104-108
Closed Access | Times Cited: 52
Modelling the impact of a Schistosoma mansoni vaccine and mass drug administration to achieve morbidity control and transmission elimination
Klodeta Kura, James E. Truscott, Jaspreet Toor, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 6, pp. e0007349-e0007349
Open Access | Times Cited: 37
Evaluating the Immunoprotective and Diagnostic Potential of Schistosoma mansoni Epitopes from Sm050890 and Sm141290 Proteins Identified Through Reverse Vaccinology
Flávio Martins de Oliveira, Gabriela Francine Martins Lopes, Rosy Iara Maciel de Azambuja Ribeiro, et al.
Acta Parasitologica (2025) Vol. 70, Iss. 1
Closed Access
“Running the Gauntlet”: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a “Call to Action”
María Elena Bottazzi, Peter J. Hotez
Human Vaccines & Immunotherapeutics (2019) Vol. 15, Iss. 10, pp. 2235-2242
Open Access | Times Cited: 25
Vaccine value profile for schistosomiasis
Gavin Yamey, Kaci Kennedy McDade, Roy M. Anderson, et al.
Vaccine (2024), pp. 126020-126020
Open Access | Times Cited: 2
Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
Benjamin Collyer, Hugo C. Turner, T. Déirdre Hollingsworth, et al.
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Mapping the epitopes of Schistosoma japonicum esophageal gland proteins for incorporation into vaccine constructs
Xiaohong Li, Gillian M. Vance, Jared Cartwright, et al.
PLoS ONE (2020) Vol. 15, Iss. 2, pp. e0229542-e0229542
Open Access | Times Cited: 15
Transmission Modelling for Human Schistosomiasis Incorporating Vaccination: Guiding Decision- and Policymaking
Ursula Panzner
(2024)
Open Access | Times Cited: 1
Sm16, ASchistosoma mansoniImmunomodulatory Protein, Fails to Elicit a Protective Immune Response and Does Not Have an Essential Role in Parasite Survival in the Definitive Host
Wilma Patrícia de Oliveira Santos Bernardes, Juliano Michel de Araújo, Gardênia Braz Figueiredo de Carvalho, et al.
Journal of Immunology Research (2019) Vol. 2019, pp. 1-16
Open Access | Times Cited: 11
How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases
Jessica Clark, Wilma A. Stolk, María‐Gloria Basáñez, et al.
Gates Open Research (2021) Vol. 5, pp. 112-112
Open Access | Times Cited: 10
The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis
Tatiane Teixeira de Melo, Mariana Moreira Mendes, Clarice Carvalho Alves, et al.
Molecular Immunology (2019) Vol. 111, pp. 172-181
Open Access | Times Cited: 7
NTDs in the 2020s: An epic struggle of effective control tools versus the Anthropocene
Peter J. Hotez
PLoS neglected tropical diseases (2020) Vol. 14, Iss. 9, pp. e0007872-e0007872
Open Access | Times Cited: 7
Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial
Andrew Abaasa, Moses Egesa, Emmanuella Driciru, et al.
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 2
How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases
Jessica Clark, Wilma A. Stolk, María‐Gloria Basáñez, et al.
Gates Open Research (2022) Vol. 5, pp. 112-112
Open Access | Times Cited: 3
Transmission Modelling for Human Non-Zoonotic Schistosomiasis Incorporating Vaccination: Guiding Decision- and Policymaking
Ursula Panzner
Parasitologia (2024) Vol. 4, Iss. 2, pp. 101-128
Open Access
A compartmental model for Schistosoma japonicum transmission dynamics in the Philippines
Yuan-Jen Kuo, Gian Paras, Taiyo Tagami, et al.
Acta Tropica (2023) Vol. 249, pp. 107084-107084
Closed Access | Times Cited: 1
T Cell Peptides Derived from Invasive Stages of Schistosoma mansoni as Potential Schistosomiasis Vaccine
Julio López‐Abán, Belén Vicente, Elías Kabbas-Piñango, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 445-445
Open Access | Times Cited: 1
Evaluation of vaccine efficacy and snail control on the transmissionof Schistosoma Haematobium in Communities around the Volta Lake in Ghana
Francis Agana, Ferdinard Obeng-Forson, William Ohene-Ayeh, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top